進行した臓がんにおける新薬:遺伝子ターゲティングを超えたピーク
Prashil Dave1, Vishal Beriwala2, Charmy Parikh3
1Internal Medicine, State University of New York Downstate Health Sciences University, Brooklyn, USA.
Cureus
|September 2, 2025
まとめ
臓がんの生存率は低いが,mFOLFIRINOXとゲムシタビン・ナブ・パクリタキセルのような新しい治療法は希望を示している. 精密医療と双極性抗体の進歩は 進行した臓がん患者の治療結果を改善しています
科学分野:
- 腫瘍学
- 胃腸内科
- 翻訳医学
背景:
- 臓がんは 低生存率で 予後が悪い
- 低所得国の診断ツールが限られているため 死亡率のデータ収集が困難です
- mFOLFIRINOXとゲムシタビン・ナブ・パクリタキセルのような標準治療は,切除可能な症例で同様の有効性を示しています.
研究 の 目的:
- 新しい臓がん治療法の最新の臨床試験結果をレビューする.
- 精密医療と組み合わせ治療の 進歩を強調する
- 新しい治療目標と免疫療法について議論する.
主な方法:
- 最近の臨床試験データに関する文献レビュー
- ネオアジュバント/外科手術後の治療の結果の分析
- 特定の分子経路と腫瘍の微小環境を標的とする新薬の試験
主要な成果:
- mFOLFIRINOXとゲムシタビン・ナブ・パクリタキセルは,切除可能な臓がんの生存率と切除率に類似しています.
- 双特定抗体や標的薬を含む新しい治療法は,初期の試験で有望であることが示されています.
- 治療可能な変異 (例えば,BRCA1/2,NRG1融合) の特定は,精密療法アプローチをサポートする.
結論:
- 革新的な組み合わせの治療法と 精密医療戦略は 進行した臓がんの治療結果を改善しています
- 特定の分子経路と 腫瘍の微小環境を標的とした 新しく開発された治療法が 新しい希望をもたらしています
- 継続的な研究と共同努力は 臓がんの課題を克服するために不可欠です
関連する概念動画
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:30Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509